Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Carvana $460 million stock offering
Davis Polk advised the joint book-running managers in connection with the $460 million public offering of 5,000,000…
Province of Ontario $1.75 billion global bond offering
Davis Polk advised the underwriters in connection with the offering of $1.75 billion aggregate principal amount of 1.050%…
Turning Point Therapeutics $325 million stock offering
Davis Polk advised the joint book-running managers in connection with a $325 million SEC-registered common stock…
Clarios International $500 million senior secured notes offering
Davis Polk advised Clarios International LP, formerly the Power Solutions business of Johnson Controls International plc, in…
Lockheed Martin $1.15 billion notes offering
Davis Polk advised the underwriters in connection with the offering of $1.15 billion aggregate principal amount of notes…
Lockheed Martin $1.15 billion notes offering
Davis Polk advised the underwriters in connection with the offering of $1.15 billion aggregate principal amount of notes…
Lockheed Martin $1.15 billion notes offering
Davis Polk advised the underwriters in connection with the offering of $1.15 billion aggregate principal amount of notes…
Clarios International $500 million senior secured notes offering
Davis Polk advised Clarios International LP, formerly the Power Solutions business of Johnson Controls International plc, in…
Province of Alberta $2.25 billion global bond offering
Davis Polk advised the underwriters in connection with the offering of $2.25 billion aggregate principal amount of 1.000%…
ADC Therapeutics $267 million IPO
Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which…